Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
Open Access
- 1 March 2007
- journal article
- case report
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (3) , 491-493
- https://doi.org/10.3201/eid1303.060960
Abstract
We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isolated from the bone of a 56-year-old man with lumbar osteomyelitis after a 6-week treatment course of vancomycin for catheter-associated septic thrombophlebitis.Keywords
This publication has 17 references indexed in Scilit:
- Roles of 34 Virulence Genes in the Evolution of Hospital‐ and Community‐Associated Strains of Methicillin‐ResistantStaphylococcus aureusThe Journal of Infectious Diseases, 2006
- An Association between Reduced Susceptibility to Daptomycin and Reduced Susceptibility to Vancomycin in Staphylococcus aureusClinical Infectious Diseases, 2006
- Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- Low Colonization Prevalence of Staphylococcus aureus with Reduced Vancomycin Susceptibility among Patients Undergoing Hemodialysis in the San Francisco Bay AreaClinical Infectious Diseases, 2005
- Community‐Adapted Methicillin‐ResistantStaphylococcus aureus(MRSA): Population Dynamics of an Expanding Community Reservoir of MRSAThe Journal of Infectious Diseases, 2004
- Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureusScience, 2003
- Pulsed-Field Gel Electrophoresis Typing of Oxacillin-ResistantStaphylococcus aureusIsolates from the United States: Establishing a National DatabaseJournal of Clinical Microbiology, 2003
- Epidemiological and Microbiological Characterization of Infections Caused byStaphylococcus aureuswith Reduced Susceptibility to Vancomycin, United States, 1997–2001Clinical Infectious Diseases, 2003
- Role of Penicillin-Binding Protein 4 in Expression of Vancomycin Resistance among Clinical Isolates of Oxacillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2001
- Involvement of Panton-Valentine Leukocidin--Producing Staphylococcus aureus in Primary Skin Infections and PneumoniaClinical Infectious Diseases, 1999